Body’s clockwork, BMAL1 and HIF2A, can influence the timing and severity of heart attacks.

BMAL1-HIF2A heterodimer modulates circadian variations of myocardial injury
Go to source).
TOP INSIGHT
Did You Know?
Timing heart treatments with the body’s natural clock could be the next big breakthrough!
#circadianhealth #medindia
Circadian Clock: The Hidden Controller of Heart Damage
Our hearts don't just beat — they follow a circadian rhythm that can decide how badly they get hurt during a heart attack. Scientists uncovered that BMAL1, a key circadian transcription factor, shapes the timing and severity of heart injury. Patients who suffer heart attacks in the morning tend to have larger infarcts and worse outcomes. BMAL1’s rhythmic action is essential to this — and its daily ups and downs open new doors to better, time-sensitive treatments.
BMAL1 and HIF2A: The Power Duo Behind Heart Protection
Digging deeper, scientists found that BMAL1 teams up with HIF2A, a hypoxia (low oxygen) response protein, to defend the heart. Under normal conditions, this dynamic duo stabilizes heart tissues and minimizes damage. However, knocking out either BMAL1 or HIF2A completely erases this natural protection, proving how vital their partnership is. Without them, the heart becomes highly vulnerable, especially during early morning hours.
Targeting Time: A New Dawn for Heart Therapies
What if we could treat heart attacks based on your body's clock? That’s the future this discovery points to. Boosting AREG, a molecule activated by BMAL1–HIF2A, shows remarkable protection against heart injury — but only if timed right. Scientists found that timed AREG therapies, circadian drugs like Nobiletin, and gene therapies dramatically improve outcomes when synchronized with the body's natural rhythms.
Reference:
- BMAL1–HIF2A heterodimer modulates circadian variations of myocardial injury- (https://www.nature.com/articles/s41586-025-08898-z)
Source-University of Texas Health Science Center at Houston
MEDINDIA



Email








